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Summary A 56-year-old woman with hypertension and hypercholesterolemia was admitted
to our hospital with acute inferior myocardial infarction. The patient had total occlusion of
the right coronary artery (RCA) segment 2, and bare-metal stents were placed. Four months
later, plain old balloon angioplasty was performed for in-stent restenosis. Follow-up coronary
angiography (CAG) 6 months later showed in-stent total occlusion, so a stent-in-stent procedure
was performed using paclitaxel-eluting stents (PESs). Four months later, the patient began
complaining of early morning chest pain at rest. CAG showed no in-stent restenosis, so coronary
spastic angina was suspected. Intracoronary infusion of ergonovine to the right and left coronary
arteries revealed spasm of the RCA with total occlusion just proximal to the PES in segment
1. Her chest pain was reproduced with ST-elevation in leads II, III, and aVF, so the diagnosis of
coronary spastic angina was made. Treatment with a Ca-channel blocker and nitrates relieved
the symptoms. The PES was the probable cause of the coronary spasm.
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Case reportA 56-year-old woman with hypertension and hypercholes-
terolemia was admitted to our hospital in September
2006 with an acute inferior myocardial infarction. She
had menopause when she was 43 years old. Coronary
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ngiography (CAG) showed total occlusion of the right
oronary artery (RCA) segment 2. A Multilink Vision stent
3.5mm× 18mm; Abbott, Tokyo, Japan) and a Driver stent
3.5mm× 24mm; Medtronic, Minneapolis, MN, USA) were
verlapped and placed. The left circumﬂex artery (LCX) was
lso signiﬁcantly stenosed, so sirolimus-eluting stents (SESs)
Cypher; Johnson & Johnson, Cordis Corporation, Miami, FL,
SA) were placed in segment 11 (3.5mm× 18mm) and seg-
ent 13 (2.5mm× 18mm) before hospital discharge.
Four months later, the patient was hospitalized for exer-
ional chest pain. CAG showed in-stent restenosis of segment
, so plain old balloon angioplasty (POBA) was performed. Six
Published by Elsevier Ireland Ltd. All rights reserved.
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rigure 1 Third percutaneous coronary intervention. (A) Coron
rtery. (B) Paclitaxel-eluting stents (PESs) were placed in the b
PES was also placed at the segment 3 90% new lesion (a: Mult
onths later, follow-up CAG revealed in-stent total occlu-
ion of segment 2 (Fig. 1A). Because this was the second
estenosis, a stent-in-stent procedure using a paclitaxel-
luting stent (PES; Taxus, Boston Scientiﬁc, San Diego, CA,
SA) was performed. Two PESs (3.5mm× 24mm) were over-
apped and placed, completely covering the bare-metal
tent (BMS). After reperfusion, a new 90% lesion in segment
was detected, so a PES (3.0mm× 12mm) was placed. The
rocedure was completed with good results (Fig. 1B).
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igure 2 Left coronary angiograms both (A) pre- and (B) post-er
oronary angiogram pre-ergonovine infusion. (D) Total occlusion of se
ust proximal to the paclitaxel-eluting stent (PES) in segments 1 a
sosorbide dinitrate 2.5mg (arrows). (F) Following additional intraco
esolved completely.ngiography shows in-stent total occlusion in the right coronary
etal stents (BMSs). The BMSs were fully covered by the PESs.
Vision stent; b: Driver stent; c, d, and e: PES).
However, 4 months later, the patient experienced early
orning chest pain at rest for the ﬁrst time. We performed
AG without an exercise test and without stopping oral
asoactive agents before CAG, because we were concerned
bout the possibility of unstable angina due to the presence
f resting chest pain. CAG showed 75% stenosis just proxi-
al to the PES in segment 1 (Fig. 2C). No other signiﬁcant
esions were present to account for the resting chest pain.
hus, a spasm provocation test using ergonovine was per-
gonovine infusion (a and b: sirolimus-eluting stent). (C) Right
gment 1 is observed after infusion. (E) Coronary spasm remains
nd 3 and just distal to the PES in segment 2 after infusion of
ronary infusion of isosorbide dinitrate, the coronary spasm has
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formed. First, ergonovine was infused into the left coronary
artery at a rate of 8g/min for 5min, but only slight vaso-
constriction was noted (Fig. 2A and B). Then, ergonovine was
similarly infused into the RCA, and within 4min, the patient
began to complain of her usual chest pain with ST-elevation
in leads II, III, and aVF. CAG revealed that the stenotic lesion
of segment 1 was totally occluded (Fig. 2D). Though intra-
coronary infusion of 2.5mg of isosorbide dinitrate achieved
reperfusion, coronary spasm remained just proximal to the
PES in segment 1 and segment 3 and just distal to the PES
in segment 2 (Fig. 2E). Again, with intracoronary infusion of
2.5mg of isosorbide dinitrate, the coronary spasm, including
the chest pain and the electrocardiogram changes, resolved
completely (Fig. 2F).
The patient had taken aspirin 200mg/day, ticlopi-
dine 200mg/day, amlodipine 5mg/day, bisoprolol 5mg/day,
lisinopril 10mg/day, and atorvastatin 10mg/day. Because
coronary spasm was demonstrated, long-acting isosorbide
dinitrate 40mg/day and benidipine 8mg/day were added.
On follow-up, the patient has had no recurrence of chest
pain at rest.
DiscussionA case of newly demonstrated coronary spasm 4 months
after PES implantation was described. Ergonovine did not
provoke coronary spasm in the LCX with SES, but clearly
provoked it with total occlusion just proximal to the PES in
the RCA.
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Table 1 Case reports of coronary spasm associated with drug-elu
Case Type of
stent
Indication
for stent
Location of
stent
Me
ide
Present report PES AP ISR in RCA CAG
El-Bialy et al. [9] PES uAP LAD Che
CAG
Kim et al. [10] PES Acute MI RCA, LAD, LCX Sud
arr
Maekawa et al. [11] SES Recent MI LAD CAG
Brott et al. [5] SES uAP LAD & diagonal Che
CAG
Brott et al. [5] SES AP ISR in LAD Che
Brott et al. [5] SES Acute MI LAD CAG
Brott et al. [5] SES uAP LCX distal Che
CAG
Brott et al. [5] SES N/A LAD via LITA CAG
Brott et al. [5] PES N/A LAD CAG
Brott et al. [5] PES N/A RCA, OM CAG
Brott et al. [5] SES AP LAD MI,
ECG
ste
Brott et al. [5] SES N/A RCA Che
(pa
AP, angina pectoris; CAG, coronary angiography; ECG, electrocardiogram
artery; LCX, left circumﬂex coronary artery; LITA, left internal thoracic
marginal branch; PCI, percutaneous coronary intervention; PES, paclitax
stent; uAP, unstable angina pectoris.ES e35
Although drug-eluting stents (DES) effectively prevent
estenosis and are nowwidely used in percutaneous coronary
ntervention (PCI), late stent thrombosis has been reported
s a major concern of DES implantation [1]. As the cause,
elayed endothelialization has been reported in DES cases
s compared to BMS cases from a histopathological per-
pective [2]. Furthermore, as compared to BMS, endothelial
ysfunction has been more often reported with DES [3,4].
he underlying mechanism of endothelial dysfunction due
o DES includes: (1) direct endothelial injury and hyper-
ensitivity reactions to the stent system (drug and polymer
oating) and (2) delayed recovery of endothelial function
ue to delayed re-endothelialization [5].
Coronary spastic angina was ﬁrst reported by Prinzmetal
t al. [6] in 1959 as variant angina. During the 1970s,
oronary artery spasm as the underlying etiology was docu-
ented by CAG [7]. A major cause of coronary artery spasm
s endothelial cell dysfunction due to a variety of factors,
uch as oxidative stress, endothelial nitric-oxide synthase
e-NOS) gene polymorphism, and chronic inﬂammation [8].
Consequently, this has been raising concerns about coro-
ary spasm due to endothelial injury associated with DES
mplantation, and there have actually been some reports
f newly demonstrated coronary spasm after DES implanta-
ion. Based on our literature search, 13 cases of coronary
pasm after SES or PES implantation, including our case,
ave been reported (Table 1) [5,9—11]. Coronary spasm in all
branches has been described, and time of onset has varied
rom during PCI to 6 months post-PCI. The site of coronary
pasm also varies from diffuse to proximal or distal to the
tent.
ting stent implantation.
thod of spasm
ntiﬁcation
Location of spasm Time to spasm
(after PCI)
RCA stent proximal 4 months
st pain, ECG,
(patent stent)
Unknown Same day
den cardiac
est CAG
Diffuse narrowing of
three coronary arteries
10 h
LAD stent distal 6 months
st pain, ECG, Diffuse, LAD&LCX 3 h
st pain, CAG Diffuse LAD&LCX 1 week
Distal to stent 4 weeks
st pain, ECG, Proximal to stent 12 h
Proximal and distal 3 h
Entire LAD&LCX During procedure
RCA, OM During procedure
chest pain,
, CAG (patent
nts)
Unknown 11 days
st pain, CAG
tent stents)
Unknown 11 days
; ISR, in-stent restenosis; LAD, left anterior descending coronary
artery; MI, myocardial infarction; N/A, not available; OM, obtuse
el-eluting stent; RCA, right coronary artery; SES, sirolimus-eluting
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Table 1 lists cases of coronary spasm associated with DES
mplantation, based on the absence of any prior symptoms
uggesting coronary spastic angina. The present patient also
rst experienced early morning chest pain at rest after
ES implantation, and, with the spasm provocation test,
otal occlusion just proximal to the PES in segment 1 was
bserved. Moreover, the spasm remained just proximal and
istal to the PES after infusion of isosorbide dinitrate. These
ndings suggest coronary spasm related to PES implantation.
owever, objective evaluation of whether DES implanta-
ion indeed caused coronary spasm was limited, because
he spasm provocation test (with negative results) was not
erformed beforehand in any of the cases, including the
resent case. In the present case, the presence of coronary
pasm was conﬁrmed by the spasm provocation test. There-
ore, we consider that the spasm provocation test should be
one in patients who complain of resting chest pain after
ES implantation, although spontaneous attacks may not be
roven to be the same as the induced attack.
The present patient also had SES in the LCX, but coro-
ary spasm did not develop at this site. There are more
ase reports of coronary spasm with SES than with PES, but
his may be inﬂuenced by their period of availability and
umber used. It would be interesting to know whether SES
nd PES differ in their ability to provoke spasm. Individual
ifferences in reactivity to drugs may exist. However, the
etails are unclear, because, unlike the present case, there
re no reports that involved implantation of both SES and
ES and that mentioned differences between the stents in
heir ability to provoke spasm.
Brott et al. [5] reported, in addition to DES cases, 3 cases
f coronary spasm after BMS implantation. Their ﬁndings
uggest that PCI itself may also cause endothelial injury,
eading to coronary spasm. In the present case, the patient
ad already undergone PCI 3 times for the PES implanta-
ion site in segment 2, so the proximal endothelium might
ave been injured by repeated PCI. In segment 3, however,
CI was performed only once, and PES was easily deployed
fter balloon predilation. Thus, we consider there was no
igniﬁcant endothelial injury due to PCI itself in segment 3.
With the additional oral medications mentioned pre-
iously, further chest pain at rest did not develop, so
rug therapy provided good control. In conclusion, coronary
pasm must always be kept in mind as a potential cause of
[K. Watanabe et al.
esting chest pain after DES implantation. However, further
nvestigation is necessary to determine whether drug ther-
py to prevent coronary spasm is required in all patients
ith DES implantation.
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